| 发明名称 |
Use of a betablocker in the manufacture of a medicament to treat artherosclerosis |
| 摘要 |
Pharmaceutical formulations comprising a betablocker, in a maintenance dose lower than 50 mg, particularly in the range of 25 to 47 mg, optionally containing a cholesterol lowering agent, in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier. A method of treatment and use of the formulations for the treatment of atherosclerosis and related diseases is also disclosed.
|
| 申请公布号 |
NZ523188(A) |
申请公布日期 |
2006.06.30 |
| 申请号 |
NZ20010523188 |
申请日期 |
2001.06.15 |
| 申请人 |
ASTRAZENECA AB |
发明人 |
BERGLUND, GORAN;WIKSTRAND, JOHN |
| 分类号 |
C07D239/42;A61K31/138;A61K31/195;A61K31/22;A61K31/366;A61K31/40;A61K31/405;A61K31/44;A61K31/4418;A61K31/505;A61K45/00;A61K45/06;A61P3/06;A61P3/10;A61P9/10;A61P9/12;A61P9/14;A61P13/12;A61P25/28;A61P31/06;A61P43/00;C07D207/34;C07D209/24;C07D213/55;C07D309/30;(IPC1-7):A61K45/00 |
主分类号 |
C07D239/42 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
